Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study

被引:0
|
作者
Tian, Yong [1 ]
Ran, Lin [1 ]
Liu, Yi [1 ]
Xu, Yu [2 ]
Shen, Juan [3 ]
Mi, Gong-sheng [3 ]
Ke, Feng-mei [1 ]
机构
[1] Wuhan Univ, Enshi Clin Coll, Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Obstet & Gynecol, Enshi, Peoples R China
[2] Sichuan Univ, West China Second Univ Hosp, Dept Obstet & Gynecol, Chengdu, Peoples R China
[3] Mianyang Cent Hosp, Dept Obstet & Gynecol, Mianyang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
lymphadenectomy; clear cell carcinoma; endometrial cancer; overall survival; disease-free survival; PELVIC LYMPHADENECTOMY; RISK-FACTORS; CANCER; CORPUS; GUIDELINES; MANAGEMENT; TRIAL;
D O I
10.3389/fonc.2022.800957
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed early-stage clear cell carcinoma of the endometrium. MethodsPatients in three Chinese teaching hospitals who presented between 2012 and 2017 with apparent early-stage clear cell carcinoma of the endometrium and underwent surgical staging were selected. Patients who did and did not undergo systematic lymphadenectomy were identified and clinicopathological characteristics were compared. Disease-free survival and overall survival were evaluated following the generation of the Kaplan-Meier curves and the comparison using the log-rank test. A Cox proportional hazards model was employed to control for confounders. ResultsA total of 244 patients underwent systematic lymphadenectomy and 89 did not receive lymph node dissection. The demographic and baseline data were comparable between the two groups. The rate of disease-free survival at 5 years was 64.10% in patients who underwent systematic lymphadenectomy and 45.05% in patients who did not undergo lymphadenectomy. Patients who underwent systematic lymphadenectomy had better disease-free survival than those who did not receive lymphadenectomy (HR, 0.54. 95% CI, 0.38-0.76. P=0.000). The rate of 5-year overall survival was 68.87% in the lymphadenectomy group and 53.33% in patients who did not undergo systematic lymphadenectomy. Systematic lymphadenectomy was also associated with improved 5-year overall survival for women with presumed early-stage clear cell carcinoma of the endometrium (HR, 0.58. 95% CI, 0.39-0.85. P=0.005). After adjusting for confounders, systematic lymphadenectomy was still independently associated with improved disease-free survival and overall survival. ConclusionPatients with apparent early-stage clear cell carcinoma of the endometrium who underwent systematic lymphadenectomy had better long-term survival than those who did not undergo systematic lymphadenectomy.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prognostic Factors and Outcomes of Early-Stage Hodgkin’s Lymphoma: Multi-Institutional Data From South India
    Lakshmi Sandhya Singuluri
    Perumal Kalaiyarasi Jayachandran
    Luxitaa Goenka
    Praveen Kumar Shenoy
    Krishna Kumar Rathnam
    Arun Seshachalam
    Nikita Mehra
    Mummoorthy Ram Kumar
    Murugan Mangai Suseela
    Vineetha Raghavan
    Chandran K. Nair
    Biswajit Dubashi
    Manikandan Dhanushkodi
    Prasanth Ganesan
    Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 237 - 245
  • [42] Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study
    Chen, Jing
    Wang, Fen-fen
    Zhang, Yan
    Yang, Bin
    Ai, Ji-hui
    Wang, Xin-yu
    Cheng, Xiao-dong
    Li, Ke-zhen
    CURRENT MEDICAL SCIENCE, 2020, 40 (04) : 745 - 752
  • [43] Oncological and Reproductive Outcomes of Fertility-sparing Surgery in Women with Early-stage Epithelial Ovarian Carcinoma: A Multicenter Retrospective Study
    Jing Chen
    Fen-fen Wang
    Yan Zhang
    Bin Yang
    Ji-hui Ai
    Xin-yu Wang
    Xiao-dong Cheng
    Ke-zhen Li
    Current Medical Science, 2020, 40 : 745 - 752
  • [44] Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis
    Kann, Benjamin H.
    Miccio, Joseph A.
    Stahl, John M.
    Ross, Rudi
    Verma, Vivek
    Dosoretz, Arie P.
    Park, Henry S.
    Shafman, Timothy D.
    Gross, Cary P.
    Yu, James B.
    Decker, Roy H.
    RADIOTHERAPY AND ONCOLOGY, 2019, 132 : 188 - 196
  • [45] THE IMPACT OF HISTOLOGICAL VARIANTS ON ONCOLOGICAL OUTCOMES AFTER SURGICAL RESECTION OF A NONMETASTATIC RENAL CELL CARCINOMA WITH TUMOR THROMBUS: A MULTI-INSTITUTIONAL STUDY
    Khene, Zine-Eddine
    Fleury, Raphael
    Bigot, Pierre
    Roupret, Morgan
    Bernhard, Jean-Christophe
    Audenet, Francois
    Waeckel, Thibaut
    Parier, Bastien
    Champy, Cecile
    Olivier, Jonathan
    Doumerc, Nicolas
    Tricard, Thibault
    Branger, Nicolas
    Bruyere, Franck
    Surlemont, Louis
    Boissier, Romain
    Patard, Jean Jacques
    Ouzaid, Idir
    Bensalah, Karim
    JOURNAL OF UROLOGY, 2024, 211 (05): : E932 - E932
  • [46] Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study
    Casarin, J.
    Buda, A.
    Bogani, G.
    Fanfani, F.
    Papadia, A.
    Ceccaroni, M.
    Malzoni, M.
    Pellegrino, A.
    Ferrari, F.
    Greggi, S.
    Uccella, S.
    Pinelli, C.
    Cromi, A.
    Ditto, A.
    Di Martino, G.
    Anchora, L. Pedone
    Falcone, F.
    Bonfiglio, F.
    Odicino, F.
    Mueller, M.
    Scambia, G.
    Raspagliesi, F.
    Landoni, F.
    Ghezzi, F.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (01) : 164 - 170
  • [47] The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional Study
    Fleury, Raphael
    Bertail, Theophile
    Bensalah, Karim
    Bernhard, Jean-Christophe
    Audent, Francois
    Waeckel, Thibaut
    Parier, Bastien
    Champy, Cecile
    Olivier, Jonathan
    Doumerc, Nicolas
    Tricard, Thibault
    Branger, Nicolas
    Bruyere, Franck
    Neuville, Paul
    Surlemont, Louis
    Long, Jean Alexandre
    Fontenil, Alexis
    Vallee, Maxime
    Roupret, Morgan
    Boissier, Romain
    Patard, Jean Jacques
    Durand, Mathieu
    Ouzaid, Idir
    Rouget, Benjamin
    Durand, Xavier
    Joncour, Charlotte
    Belas, Olivier
    Gomez, Florie Denise
    Bigot, Pierre
    Khene, Zine-Eddine
    EUROPEAN UROLOGY OPEN SCIENCE, 2024, 62 : 123 - 130
  • [48] Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study
    May, Taymaa
    Altman, Alon
    McGee, Jacob
    Lu, Lin
    Xu, Wei
    Lane, Kelly
    Ghatage, Prafull
    Rosen, Barry
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (05) : 925 - 931
  • [49] Variable survival outcomes in Australian patients with very early-stage and early-stage hepatocellular carcinoma: A retrospective multicenter cohort study
    Abdelmalak, J.
    Lam, E.
    Greenhill, E.
    Zalcberg, J.
    Roberts, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 71 - 72
  • [50] Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients
    Holcomb, Andrew J.
    Farrokhian, Nathan
    Tolan, Claire
    Whiteford, Erin
    Villwock, Mark
    Kakarala, Kiran
    Shnayder, Yelizaveta
    Sykes, Kevin
    Lominska, Christopher
    Gan, Gregory
    Buchakjian, Marisa R.
    Harding, Brette
    Dooley, Laura
    Shinn, Justin
    Wood, C. Burton
    Rohde, Sarah
    Khaja, Sobia
    Abt, Nicholas B.
    Varvares, Mark
    Bur, Andres M.
    ORAL ONCOLOGY, 2023, 142